Abeona Therapeutics (FRA:PCJ) Accounts Payable & Accrued Expense : €8.76 Mil (As of Mar. 2024)

View and export this data going back to 1980. Start your Free Trial

What is Abeona Therapeutics Accounts Payable & Accrued Expense?

Abeona Therapeutics's quarterly accounts payable & accrued expense increased from Sep. 2023 (€4.16 Mil) to Dec. 2023 (€8.01 Mil) and increased from Dec. 2023 (€8.01 Mil) to Mar. 2024 (€8.76 Mil).

Abeona Therapeutics's annual accounts payable & accrued expense declined from Dec. 2021 (€11.25 Mil) to Dec. 2022 (€3.03 Mil) but then increased from Dec. 2022 (€3.03 Mil) to Dec. 2023 (€8.01 Mil).

Abeona Therapeutics Accounts Payable & Accrued Expense Historical Data

The historical data trend for Abeona Therapeutics's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abeona Therapeutics Accounts Payable & Accrued Expense Chart

Abeona Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

33.04

32.57

11.25

3.03

8.01

Abeona Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															4.29	5.73	4.16	8.01	8.76

Abeona Therapeutics Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Abeona Therapeutics (FRA:PCJ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abeona Therapeutics Inc (FRA:PCJ) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

ABEO:USA

Address

1330 Avenue of the Americas, 33rd Floor, New York, NY, USA, 10019

Website

https://www.abeonatherapeutics.com

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its lead clinical programs consist of EB-101, autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa; ABO-102, adeno-associated virus-based gene therapy for Sanfilippo syndrome type A, and ABO-101, an AAV-based gene therapy for Sanfilippo syndrome type B.

Abeona Therapeutics (FRA:PCJ) Headlines

No Headlines